143 related articles for article (PubMed ID: 36208705)
1. Reduced expression and activity of patient-derived SHIP1 phosphatase domain mutants.
Ehm P; Nelson N; Giehler S; Schaks M; Bettin B; Kirchmair J; Jücker M
Cell Signal; 2023 Jan; 101():110485. PubMed ID: 36208705
[TBL] [Abstract][Full Text] [Related]
2. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the FLVR motif of SHIP1 and its importance for the protein stability of SH2 containing signaling proteins.
Ehm PAH; Lange F; Hentschel C; Jepsen A; Glück M; Nelson N; Bettin B; de Bruyn Kops C; Kirchmair J; Nalaskowski M; Jücker M
Cell Signal; 2019 Nov; 63():109380. PubMed ID: 31377397
[TBL] [Abstract][Full Text] [Related]
4. Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells.
Nalaskowski MM; Ehm P; Rehbach C; Nelson N; Täger M; Modest K; Jücker M
Cell Signal; 2018 Sep; 49():87-94. PubMed ID: 29852247
[TBL] [Abstract][Full Text] [Related]
5. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.
Täger M; Horn S; Latuske E; Ehm P; Schaks M; Nalaskowski M; Fehse B; Fiedler W; Stocking C; Wellbrock J; Jücker M
Gene Ther; 2017 Nov; 24(11):749-753. PubMed ID: 29143813
[TBL] [Abstract][Full Text] [Related]
6. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
[TBL] [Abstract][Full Text] [Related]
7. JAK2-V617F is a negative regulation factor of SHIP1 protein and thus influences the AKT signaling pathway in patients with Myeloproliferative neoplasm (MPN).
Glück M; Dally L; Jücker M; Ehm P
Int J Biochem Cell Biol; 2022 Aug; 149():106229. PubMed ID: 35609769
[TBL] [Abstract][Full Text] [Related]
8. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
9. SHIP1 and its role for innate immune regulation-Novel targets for immunotherapy.
Yeoh WJ; Krebs P
Eur J Immunol; 2023 Dec; 53(12):e2350446. PubMed ID: 37742135
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
Waddell GL; Drew EE; Rupp HP; Hansen SD
J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
[TBL] [Abstract][Full Text] [Related]
11. SHIP1 regulates MSC numbers and their osteolineage commitment by limiting induction of the PI3K/Akt/β-catenin/Id2 axis.
Iyer S; Viernes DR; Chisholm JD; Margulies BS; Kerr WG
Stem Cells Dev; 2014 Oct; 23(19):2336-51. PubMed ID: 24857423
[TBL] [Abstract][Full Text] [Related]
12. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
[TBL] [Abstract][Full Text] [Related]
13. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL.
Sattler M; Verma S; Pride YB; Salgia R; Rohrschneider LR; Griffin JD
J Biol Chem; 2001 Jan; 276(4):2451-8. PubMed ID: 11031258
[TBL] [Abstract][Full Text] [Related]
14. A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).
Zhang J; Ravichandran KS; Garrison JC
J Biol Chem; 2010 Nov; 285(45):34839-49. PubMed ID: 20810657
[TBL] [Abstract][Full Text] [Related]
15. Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT.
Vanderwinden JM; Wang D; Paternotte N; Mignon S; Isozaki K; Erneux C
Cell Signal; 2006 May; 18(5):661-9. PubMed ID: 15990278
[TBL] [Abstract][Full Text] [Related]
16. Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2.
Bradshaw WJ; Kennedy EC; Moreira T; Smith LA; Chalk R; Katis VL; Benesch JLP; Brennan PE; Murphy EJ; Gileadi O
Structure; 2024 Apr; 32(4):453-466.e6. PubMed ID: 38309262
[TBL] [Abstract][Full Text] [Related]
17. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
Zhang J; Walk SF; Ravichandran KS; Garrison JC
J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
[TBL] [Abstract][Full Text] [Related]
19. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
20. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
